These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 833742)

  • 41. [Elimination of triamterene, an antikaliuretic, and its phenolic metabolite, 2,4,7-triamino-6-p-hydroxyphenylpteridine, in the urine of subjects with normal liver function and in subjects suffering from liver cirrhosis].
    Andrasch H; Fink T; Schmid E
    Z Gastroenterol; 1971; 9(4):240-5. PubMed ID: 5164739
    [No Abstract]   [Full Text] [Related]  

  • 42. Tissue distribution and pharmacokinetics of 3-t-[methyl-14C] butyl-4-hydroxyanisole in rats.
    Ansari GA; Hendrix PY
    Drug Metab Dispos; 1985; 13(5):535-41. PubMed ID: 2865099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats.
    Siefert HM; Maruhn D; Scholl H
    Arzneimittelforschung; 1986 Oct; 36(10):1503-10. PubMed ID: 3101707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of trimethoprim in the rat.
    Tu YH; Allen LV; Fiorica VM; Albers DD
    J Pharm Sci; 1989 Jul; 78(7):556-60. PubMed ID: 2778654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Placental transfer of a substituted pteridine from fetus to mother.
    McNay JL; Dayton PG
    Science; 1970 Feb; 167(3920):988-90. PubMed ID: 5411178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic fate and solubility of triamterene--not an explanation for triamterene nephrolithiasis.
    Sörgel F; Ettinger B; Benet LZ
    J Pharm Sci; 1986 Feb; 75(2):129-32. PubMed ID: 3958920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rate-limiting biotransformation of triamterene is mediated by CYP1A2.
    Fuhr U; Kober S; Zaigler M; Mutschler E; Spahn-Langguth H
    Int J Clin Pharmacol Ther; 2005 Jul; 43(7):327-34. PubMed ID: 16035375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tissue distribution and plasma pharmacokinetics of UCN-01 at steady-state and following bolus administration in rats: influence of human alpha1-acid glycoprotein binding.
    Hedaya MA; Daoud SS
    Anticancer Res; 2001; 21(6A):4005-10. PubMed ID: 11911284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetics of tissue distribution and elimination of retinoid drugs in the rat. I. Acitretin.
    Eisenhardt EU; Bickel MH
    Drug Metab Dispos; 1994; 22(1):26-30. PubMed ID: 8149885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of triclosan in rat after intravenous and intravaginal administration.
    Siddiqui WH; Buttar HS
    J Environ Pathol Toxicol; 1979; 2(3):861-71. PubMed ID: 422939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Distribution of the 14C-hydrated analog of phenazepam in the organs and tissues of mice].
    Golovenko NIa; Sozinov VA; Rudenko OP
    Biull Eksp Biol Med; 1986 Mar; 101(3):327-9. PubMed ID: 2869800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of potassium chloride and triamterene on kaliuresis, natriuresis and diuresis in congestive heart failure].
    Kabakov AI; Zharov EI
    Klin Med (Mosk); 1995; 73(5):33-5. PubMed ID: 8815272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro inhibition of rat kidney plasma membrane Na-K-ATPase activity by triamterene.
    Ozegović B; Milković S
    Arzneimittelforschung; 1982; 32(10):1279-81. PubMed ID: 6129855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) in the mouse.
    Newell DR; Alison DL; Calvert AH; Harrap KR; Jarman M; Jones TR; Manteuffel-Cymborowska M; O'Connor P
    Cancer Treat Rep; 1986 Aug; 70(8):971-9. PubMed ID: 3731153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and metabolic disposition of 14C-metronidazole-derived radioactivity in rat after intravenous and intravaginal administration.
    Buttar HS; Siddiqui WH
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):4-19. PubMed ID: 7406601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of Nimodipine. II. Communication: distribution, elimination and placental transfer in rats following single and multiple doses of [14C]nimodipine.
    Suwelack D; Weber H; Maruhn D
    Arzneimittelforschung; 1985; 35(12):1787-94. PubMed ID: 4096730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diuresis and natriuresis following application of bemeticide and triamterence in rats on normal and low-potassium diet (author's transl)].
    Biach B
    Arzneimittelforschung; 1977; 27(5):1026-34. PubMed ID: 577865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetics of monochloroacetic acid in adult male rats after intravenous injection of a subtoxic and a toxic dose.
    Saghir SA; Fried K; Rozman KK
    J Pharmacol Exp Ther; 2001 Feb; 296(2):612-22. PubMed ID: 11160650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.